Ambrosia Drugs Private Limited, a active private limited company, was established on 16 June 2004 in Haridwar, Uttarakhand, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397UR2004PTC028742. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹8.50 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Sunil Arora (Director), Bhawani Singh (Director). Past directors included Vandana Arora, Sunil Arora, Bablesh Kumar Saini. It holds ₹4.67 Cr open charges and ₹5.88 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 30 Civil Lines Roorkee, Haridwar, Uttarakhand.
U51397UR2004PTC028742
028742
16 June 2004
₹8.50 M
₹5.00 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Ambrosia Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Arora | Director | 20 Mar 2016 | Current |
| Bhawani Singh | Director | 19 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2013 | Past |
| Pramod Abcsdd | Director | 07 May 2015 | Past |
| Pramod Abcsdd | Director | 06 Apr 2010 | Past |
| Pramod Abcsdd | Director | 11 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 03 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ambrosia Drugs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 175.3% increase. The company also saw a substantial improvement in profitability, with a 72.67% increase in profit. The company's net worth dipped by a decrease of 4.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ambrosia Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹46,674,725.00
₹58,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2018 | Others | ₹2.54 M | Open |
| 11 Feb 2018 | Others | ₹4.41 Cr | Open |
| 27 Jan 2016 | Others | ₹3.50 Cr | Satisfied |
| 27 Jan 2016 | Others | ₹3.75 M | Satisfied |
| 17 Aug 2014 | Central Bank Of India | ₹1.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ambrosia Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ambrosia Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambrosia Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bhawani Singh was appointed as a Director was appointed as a Director on 19 Oct 2025 & has been associated with this company since 2 months 5 days . was recorded as a recent event.
Ambrosia Drugs Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was recorded as a recent event.
Ambrosia Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.54 M with Charge ID 100158086 was registered on 24 Feb 2018. was documented.
The activity A charge registered on 27 Jan 2016 via Charge ID 100052007 with Others was fully satisfied on 17 Feb 2018. was completed.
The activity A charge registered on 27 Jan 2016 via Charge ID 100051997 with Others was fully satisfied on 17 Feb 2018. was completed.
The CIN of Ambrosia Drugs Private Limited is U51397UR2004PTC028742.
Ambrosia Drugs Private Limited is headquartered at 30 Civil Lines Roorkee, Haridwar, Uttarakhand.
Ambrosia Drugs Private Limited was incorporated on 16 June 2004.
The current directors of Ambrosia Drugs Private Limited are
The primary industry of Ambrosia Drugs Private Limited is Trade.
Ambrosia Drugs Private Limited is unlisted.
The authorized capital of Ambrosia Drugs Private Limited is ₹8.50 M, and the paid-up capital is ₹5.00 M.
The compliance status of Ambrosia Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX